Login / Signup

Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial.

Pauline Byakika-KibwikaJane AchanMohammed LamordeCarine Karera-GonahasaAgnes N KiraggaHarriet Mayanja-KizzaNoah KiwanukaSam NsobyaAmbrose O TalisunaConcepta Merry
Published in: BMC infectious diseases (2017)
The study was registered with the Pan African Clinical Trial Registry ( PACTR201110000321348 ).
Keyphrases
  • combination therapy
  • clinical trial
  • high dose
  • young adults
  • early onset
  • study protocol
  • phase ii
  • randomized controlled trial
  • open label
  • low dose
  • double blind
  • phase iii